Literature DB >> 16277889

North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer.

Alvaro Moreno-Aspitia1, Edith A Perez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16277889     DOI: 10.3816/CBC.2005.n.042

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  2 in total

Review 1.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

2.  Gemcitabine and taxanes in metastatic breast cancer: a systematic review.

Authors:  Vinay Gudena; Alberto J Montero; Stefan Glück
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.